从“工程师红利”到“科学家红利”，双重优势如何助力中国制造出海

Core Viewpoint - China is transitioning from an "engineer dividend" to a "scientist dividend," indicating a shift towards advanced technology and innovation in various industries, particularly in biopharmaceuticals and shipbuilding [3]. Group 1: Biopharmaceuticals - The revenue from technology licensing in China's biopharmaceutical and gene pharmaceutical sectors reached $135 billion in the previous year, showcasing significant growth from a focus on raw materials and generic drugs [3]. - A major report on liver cancer prevention and treatment, led by Chinese scholars, was published in The Lancet, marking a historic achievement for Chinese research in global health [7]. Group 2: Shipbuilding Industry - Chinese shipbuilders, particularly Hudong-Zhonghua, have gained international orders due to superior technology and quality, with a strategic focus on high-value ship types like LNG carriers and ultra-large container ships [4]. - In 2025, China is projected to complete 53.69 million deadweight tons of shipbuilding, accounting for 56.1% of the global total, with new orders reaching 107.82 million deadweight tons, representing 69.0% of the global market [5]. - The market share of Chinese shipbuilders in the LNG sector has improved significantly, with the ratio of Chinese to Korean market share narrowing from 1:9 to 3:7 [4]. Group 3: Nuclear Energy - China has developed a fifth-generation nuclear energy system, termed "Chinese Hedianbao," which has been recognized internationally and is characterized by its small size, modularity, and long-term stable operation [7][8]. - The "nuclear treasure" technology is expected to play a crucial role in providing stable, low-carbon power for various applications, including remote areas and high-load computing centers, highlighting its potential in international markets [8].